Fig. 4: SARS-CoV-2 RNA titers in the nasopharyngeal and tracheal compartments. | Nature Communications

Fig. 4: SARS-CoV-2 RNA titers in the nasopharyngeal and tracheal compartments.

From: Whole-body visualization of SARS-CoV-2 biodistribution in vivo by immunoPET imaging in non-human primates

Fig. 4: SARS-CoV-2 RNA titers in the nasopharyngeal and tracheal compartments.The alternative text for this image may have been generated using AI.

Evaluation of the SARS-CoV-2 genomic RNA (gRNA) titers (Log10 copies/mL) over two weeks in the nasopharynx (a) and trachea (b). The individual follow-up is represented by the thin lines and the average (mean) of each group by the bold lines. Horizontal dotted line: limit of quantification (LoQ)/limit of detection (LoD), vertical dotted line: euthanasia (n = 2) during the acute phase of the infection. SARS-CoV-2 gRNA titers (log10 copies/mL) showing the individual peak values for each group in the nasopharynx (c) and trachea (d). Area under the curve (AUC) calculated for each group in the nasopharynx (e) and trachea (f). The Mock + COVA group is indicated in black (n = 3 animals), the exposed + COVA group in turquoise (n = 4 animals), and the exposed + IgG group in pink (n = 2 animals). c–f Data are presented as individual values (circles) with the mean and standard deviation. Source data are provided as a Source data file.

Back to article page